Avestin EmulsiFlex-C55 High-Pressure Homogenizer

Overview

The Avestin EmulsiFlex-C55 is a high-pressure homogenizer engineered for precision nanoscale particle size reduction, cell disruption, and sterile formulation development in regulated pharmaceutical, biotechnology, and academic research environments. Utilizing controlled microfluidic shear and cavitation within a fixed-geometry interaction chamber, the EmulsiFlex-C55 achieves reproducible sub-100 nm particle size distributions—critical for liposome encapsulation, nanoemulsion stabilization, nanoparticle suspension, and intracellular protein extraction. Its validated 30,000 psi (207 MPa) pressure capability enables consistent processing across batch and continuous modes, supporting both R&D-scale optimization and pilot-scale process transfer. Designed and assembled in Ottawa, Canada, the system adheres to ISO 13485–certified manufacturing practices and integrates hardware-level safeguards to meet stringent regulatory expectations for equipment qualification (IQ/OQ/PQ) under GMP and GLP frameworks.

Key Features

• Pneumatic dual-piston drive system eliminates electrical brush dust, gearbox oil, or hydraulic fluid contamination—ensuring intrinsic sample purity and simplifying cleaning validation.
• Self-lubricating ceramic-coated plunger assembly requires no external lubrication water, removing a major source of microbial ingress and cross-contamination.
• GMP-compliant diaphragm-type pressure transducer replaces traditional oil-filled Bourdon gauges, eliminating risk of oil migration into product pathways.
• Double-ended tubular heat exchanger isolates cooling medium from process fluid—fully compliant with USP <1043> requirements for sterile barrier integrity.
• Electropolished 316L stainless steel wetted surfaces (Ra ≤ 0.4 µm) support verifiable SIP (steam-in-place) and CIP (clean-in-place) cycles per ASME BPE-2022 standards.
• No O-rings, gaskets, or dead-leg geometries in product-contact zones—enabling full disassembly, visual inspection, and residue-free cleaning.
• Integrated overpressure protection circuitry allows transient operation up to 120% of setpoint pressure without system shutdown, enhancing process robustness during viscosity transitions.

Sample Compatibility & Compliance

The EmulsiFlex-C55 accommodates aqueous, organic, and mixed-phase formulations—including lipid suspensions, polymer dispersions, viral vectors, bacterial lysates, and monoclonal antibody aggregates—with minimal thermal load (< 5 °C temperature rise per pass at nominal flow). All wetted components comply with FDA 21 CFR 178.3570 (food-contact materials) and USP Class VI biological reactivity standards. The system’s architecture supports full traceability per FDA 21 CFR Part 11 when paired with validated third-party SCADA or MES platforms—enabling audit-ready electronic records, user access controls, and immutable audit trails for change management. Documentation packages include DQ/IQ/OQ protocols aligned with ICH Q5A(R2), Q5D, and Annex 1 (EU GMP) requirements.

Software & Data Management

While the EmulsiFlex-C55 operates via analog pressure control with mechanical safety interlocks, it features standardized 4–20 mA analog outputs and dry-contact relay signals compatible with industrial PLCs (e.g., Siemens S7, Rockwell ControlLogix) and validated LIMS/SCADA systems. Optional digital interface modules provide Modbus RTU/TCP connectivity for real-time pressure, temperature, and flow monitoring. All configuration changes, runtime events, and alarm logs can be captured externally with time-stamped, user-identified entries—meeting ALCOA+ data integrity principles (Attributable, Legible, Contemporaneous, Original, Accurate, Complete, Consistent, Enduring, Available). Raw operational data is exportable in CSV format for statistical process control (SPC) analysis using JMP or Minitab.

Applications

• Liposome and extracellular vesicle production for mRNA delivery and vaccine development
• Nanosuspension formulation of poorly water-soluble APIs (BCS Class II/IV)
• Cell lysis of Gram-negative and Gram-positive bacteria, yeast, and mammalian cells
• Preparation of stable oil-in-water and water-in-oil nanoemulsions for dermal and oral delivery
• Deagglomeration of nanocrystalline active ingredients prior to lyophilization or spray drying
• Generation of uniform polymeric nanoparticles (PLGA, chitosan) for controlled release profiling
• Processing of high-viscosity biopolymer solutions (e.g., hyaluronic acid, alginate) without thermal degradation

FAQ

What is the minimum viable sample volume for method development?
The EmulsiFlex-C55 supports repeatable processing down to 7 mL—ideal for early-stage formulation screening where material is scarce or costly.
Can the system be qualified for GMP manufacturing use?
Yes. Full IQ/OQ documentation templates are provided, and all wetted materials carry mill test reports (MTRs) per ASTM A240/A276. Electropolishing certification and surface finish verification reports are included.
Is steam sterilization (SIP) validated for this unit?
The entire product pathway—including valve manifolds, interaction chamber, and discharge tubing—is designed for 121 °C saturated steam exposure with full temperature mapping capability. Validation support files are available upon request.
How does the pneumatic drive compare to electric or hydraulic alternatives in terms of reliability?
Pneumatic actuation delivers superior long-term stability: no motor brush wear, zero hydraulic oil degradation, and no risk of seal failure due to thermal cycling—resulting in >98% uptime over 5-year service intervals under continuous operation.
Are spare parts and technical support available globally?
Avestin maintains certified service centers in North America, Europe, and APAC regions. Critical spares (plungers, seals, interaction chambers) are stocked with <72-hour dispatch guarantee under standard warranty terms.